Tumefactive Demyelinating Lesions in a Patient With Multiple Sclerosis Developed Two Days After the Injection of Rituximab

Tumefactive Demyelinating Lesions in a Patient With Multiple Sclerosis Developed Two Days After the Injection of Rituximab Pubmed

Moghadasi AN¹

Show Affiliations

1. MS Research Center, Neuroscience institute, Tehran University of Medical Sciences, Tehran, Iran

Source: Acta neurologica Taiwanica Published:2020

Abstract

BACKGROUND: Rituximab has been increasingly prescribed in the treatment of multiple sclerosis (MS) over recent years. Tumefactive demyelinating lesions can occur at the onset or over the course of MS. Another major cause of these lesions is the side effects of drugs such as natalizumab or fingolimod. This study is a case report of a young MS patient who suffered from tumefactive lesions following the injection of rituximab. CASE PRESENTATION: The patient was an 18-year-old man with MS who developed double vision, imbalance, and quadriparesis symptoms followed by a decrease in his consciousness two days after administration of rituximab. Tumefactive lesions were observed in the patient's brain magnetic resonance imaging (MRI). CONCLUSION: Rituximab should be considered as a potential cause of tumefactive demyelinating lesions in patients with MS.

Style	Citing Format
MLA	Moghadasi AN. "Tumefactive Demyelinating Lesions in a Patient With Multiple Sclerosis Developed Two Days After the Injection of Rituximab." Acta neurologica Taiwanica, vol. 29(4), no. , 2020, pp. 124-127.
APA	Moghadasi AN (2020). Tumefactive Demyelinating Lesions in a Patient With Multiple Sclerosis Developed Two Days After the Injection of Rituximab. Acta neurologica Taiwanica, 29(4)(), 124-127.
Chicago	Moghadasi AN. "Tumefactive Demyelinating Lesions in a Patient With Multiple Sclerosis Developed Two Days After the Injection of Rituximab." Acta neurologica Taiwanica 29(4), no. (2020): 124-127.
Harvard	Moghadasi AN (2020) 'Tumefactive Demyelinating Lesions in a Patient With Multiple Sclerosis Developed Two Days After the Injection of Rituximab', Acta neurologica Taiwanica, 29(4)(), pp. 124-127.
Vancouver	Moghadasi AN. Tumefactive Demyelinating Lesions in a Patient With Multiple Sclerosis Developed Two Days After the Injection of Rituximab. Acta neurologica Taiwanica. 2020;29(4)():124-127.
BibTex	@article{ author = {Moghadasi AN}, title = {Tumefactive Demyelinating Lesions in a Patient With Multiple Sclerosis Developed Two Days After the Injection of Rituximab}, journal = {Acta neurologica Taiwanica}, volume = {29(4)}, number = {}, pages = {124-127}, year = {2020} }
RIS	TY - JOUR AU - Moghadasi AN TI - Tumefactive Demyelinating Lesions in a Patient With Multiple Sclerosis Developed Two Days After the Injection of Rituximab JO - Acta neurologica Taiwanica VL - 29(4) IS - SP - 124 EP - 127 PY - 2020 ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract